These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8911706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB, Greiner JV.
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP.
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [Abstract] [Full Text] [Related]

  • 9. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C, Metzenauer P, Petzold U, Ellers-Lenz B.
    Curr Med Res Opin; 2000 Sep; 16(3):153-63. PubMed ID: 11191004
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA, Ruprecht KW.
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [Abstract] [Full Text] [Related]

  • 11. Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge.
    Ciprandi G, Buscaglia S, Pronzato C, Benvenuti C, Cavalli E, Bruzzone F, Canonica GW.
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):446-52. PubMed ID: 7583868
    [Abstract] [Full Text] [Related]

  • 12. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J, Morgan G, Tieu D, Schwalb TA, Luo JY, Wheeler LA, Stern ME.
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [Abstract] [Full Text] [Related]

  • 13. Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine.
    Qasem AR, Bucolo C, Baiula M, Spartà A, Govoni P, Bedini A, Fascì D, Spampinato S.
    Biochem Pharmacol; 2008 Sep 15; 76(6):751-62. PubMed ID: 18680729
    [Abstract] [Full Text] [Related]

  • 14. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G, Cerqueti PM, Sacca S, Cilli P, Canonica GW.
    Ann Allergy; 1990 Aug 15; 65(2):156-8. PubMed ID: 1974402
    [Abstract] [Full Text] [Related]

  • 15. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C, Wagenmann M, Vossen-Holzenkamp S.
    Rhinology; 1996 Sep 15; 34(3):140-3. PubMed ID: 8938880
    [Abstract] [Full Text] [Related]

  • 16. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Danzig M, Canonica GW.
    Clin Exp Allergy; 1997 Oct 15; 27(10):1175-83. PubMed ID: 9383258
    [Abstract] [Full Text] [Related]

  • 17. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients.
    Pestelli E, Floriani I, Fabbri P, Caproni M.
    Int J Tissue React; 2003 Oct 15; 25(1):1-8. PubMed ID: 12854881
    [Abstract] [Full Text] [Related]

  • 18. Modulation of HLA-DR antigen and ICAM-1 molecule expression on airway epithelial cells by sodium nedocromil.
    Sacco O, Lantero S, Scarso L, Galietta LJ, Spallarossa D, Silvestri M, Rossi GA.
    Ann Allergy Asthma Immunol; 1999 Jul 15; 83(1):49-54. PubMed ID: 10437816
    [Abstract] [Full Text] [Related]

  • 19. Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test.
    Ciprandi G, Buscaglia S, Pesce GP, Iudice A, Bagnasco M, Canonica GW.
    Allergy; 1993 Aug 15; 48(6):421-30. PubMed ID: 7902021
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM, Tekelioglu Y, Turk A, Akyol N.
    Clin Ther; 2005 Sep 15; 27(9):1392-402. PubMed ID: 16291412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.